Filing Details

Accession Number:
0001209191-14-003513
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-01-16 16:50:31
Reporting Period:
2014-01-15
Filing Date:
2014-01-16
Accepted Time:
2014-01-16 16:50:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1237831 Globus Medical Inc GMED Surgical & Medical Instruments & Apparatus (3841) 043744954
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1555392 M David Demski Valley Forge Business Center
2560 General Armistead Avenue
Audubon PA 19403
President And Coo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Disposition 2014-01-15 96,813 $20.51 381,365 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Class A Common Stock Stock Option (Right to Buy Class A Common Stock) $4.88 2019-08-06 18,461 18,461 Direct
Class A Common Stock Stock Option (Right to Buy Class A Common Stock) $11.87 2020-06-16 18,461 18,461 Direct
Class A Common Stock Stock Option (Right to Buy Class A Common Stock) $10.66 2021-10-27 18,461 18,461 Direct
Class A Common Stock Stock Option (Right to Buy Class A Common Stock) $15.34 2022-08-29 15,000 15,000 Direct
Class A Common Stock Stock Option (Right to Buy Class A Common Stock) $13.04 2023-01-24 40,000 40,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2019-08-06 18,461 18,461 Direct
2020-06-16 18,461 18,461 Direct
2021-10-27 18,461 18,461 Direct
2022-08-29 15,000 15,000 Direct
2023-01-24 40,000 40,000 Direct
Footnotes
  1. This sale was pursuant to a Rule 10b5-1 Sales Plan dated September 9, 2013 and effective on October 9, 2013, which is intended to comply with Rule 10b5-1.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.25 to $20.75, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
  3. These options were granted on August 6, 2009, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2010, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
  4. These options were granted on June 16, 2010, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2011, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
  5. These options were granted on October 27, 2011, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2012, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
  6. These options were granted on August 29, 2012, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2013, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
  7. These options were granted on January 24, 2013, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2014, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.